2[1]Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood - pressure lowering and low - dose aspirin in patient with hypertension :principal results of the Hypertension Optimal Treatment(HOT) randomized trial. Lancet, 1998,351: 1755～1762 被引量：1
3[2]The SHEP Cooperative Research Group, JAMA, 1991,265:3255 被引量：1
4[4]WHO - ISH guidelines for the management of hypertension. J Hypertens,1999,17:151～183 被引量：1
5[7]CIBIS Ⅱ Investigators and Committees. The cardiac insufficiency bisoprolol study Ⅱ: A randomised trial. Lancet, 1999,353:9～13 被引量：1
6[8]Hansson L, Lindholm LH, Niskanen L, et al. Effect of ACEI compared with conventional therapy on cardiovascular morbidity and mortality in hypertension. The Captopril Prevention Project (CAPPP) randomized trial. Lancet, 1999,353: 611 被引量：1
7[9]Yusuf S, Sleight P, Pogue J, et al. Effect of an ACEI ramipril, on cardiovascular events in high - risk pt. The HOPE Investigators. New E J MED,2000,342:145 被引量：1
8Lopez-Sendon J,Swedberg K,McMurray J,et al.Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease.The Task Force on ACE-inhibitors of the European Society of Cardiology.Eur Heart J,2004,25(16):1454-1470. 被引量：1
9The Heart Outcomes Prevention Evaluation Study Investigators.Effects of an angiotensin-converting-enzyme inhibitor,ramipril,on cardiovascular events in high-risk patients.N Engl J Med,2000,342 (3):145-153. 被引量：1
10The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).JAMA,2002,288 (23):2981-2997. 被引量：1
